BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 29556781)

  • 1. Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis.
    Thöne K; Rudolph A; Obi N; Chang-Claude J; Flesch-Janys D
    Breast Cancer Res Treat; 2018 Jul; 170(2):381-390. PubMed ID: 29556781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
    van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
    Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 5. Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis.
    Goldberg M; Sutradhar R; Paszat L; Whelan TJ; Gu S; Fong C; Rakovitch E
    Breast Cancer Res Treat; 2019 Aug; 176(3):657-667. PubMed ID: 31076954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
    Ann Surg Oncol; 2015 Nov; 22(12):3836-45. PubMed ID: 25743325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery.
    Orozco JIJ; Keller JK; Chang SC; Fancher CE; Grumley JG
    Ann Surg Oncol; 2022 Oct; 29(10):6299-6310. PubMed ID: 35896922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after Breast-Conserving Surgery with Whole Breast or Partial Breast Irradiation in Women with Early Stage Breast Cancer: A SEER Data-base Analysis.
    Grover S; Nurkic S; Diener-West M; Showalter SL
    Breast J; 2017 May; 23(3):292-298. PubMed ID: 27988987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma.
    Yu TJ; Liu YY; Hu X; Di GH
    Eur J Surg Oncol; 2018 Nov; 44(11):1703-1707. PubMed ID: 30029824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-stage young breast cancer patients: impact of local treatment on survival.
    Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
    Wan Q; Su L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    JAMA Netw Open; 2021 Apr; 4(4):e216259. PubMed ID: 33890992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of local therapy on locoregional recurrence in postmenopausal women with breast cancer in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial.
    van Hezewijk M; Bastiaannet E; Putter H; Scholten AN; Liefers GJ; Rea D; Hasenburg A; Paridaens R; Hozumi Y; Markopoulos C; Seynaeve C; Jones SE; Marijnen CA; van de Velde CJ
    Radiother Oncol; 2013 Aug; 108(2):190-6. PubMed ID: 24044798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival.
    van Maaren MC; Bretveld RW; Jobsen JJ; Veenstra RK; Groothuis-Oudshoorn CG; Struikmans H; Maduro JH; Strobbe LJ; Poortmans PM; Siesling S
    Br J Cancer; 2017 Jul; 117(2):179-188. PubMed ID: 28588320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort.
    Jeon YW; Choi JE; Park HK; Kim KS; Lee JY; Suh YJ
    Breast Cancer Res Treat; 2013 Apr; 138(2):475-84. PubMed ID: 23456232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison.
    Ye JC; Yan W; Christos PJ; Nori D; Ravi A
    Clin Breast Cancer; 2015 Oct; 15(5):390-7. PubMed ID: 25957740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality impact of less-than-standard therapy in older breast cancer patients.
    Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
    J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.